Announcements Trials
Browse Landscape

Phase

Phase NA 49Phase 3 4Phase 4 3Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Motor Activity 2Weight Loss 1Patient Compliance 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Diet × Clear all
NCT01708824 2016-05-12

Diet and Physical Activity Intervention in CRC Survivors

The University of Hong Kong

Phase 2 Unknown
224 enrolled
Gastrointestinal

Motor Activity, Patient Compliance, Colorectal Neoplasms

NCT02067481 2014-02-20

PREDICOP-F

Institut Català d'Oncologia

Phase 2 Completed
42 enrolled
Breast

Breast Neoplasms, Motor Activity, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡